HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Merocyanine I

HCID 23678802
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
58823-12-4
Standard SMILES
CCCCN1C(=O)C(=C/C=C/C=C2\Oc3ccccc3N2CCCS(=O)(=O)[O-])C(=O)N(CCCC)C1=O.[Na+]
InChIKey
DZVCFNFOPIZQKX-LTHRDKTGSA-M
Molecular formula
C26H32N3NaO7S
Average molar mass
553.6 g/mol
Monoisotopic mass
553.18586582

Overview

fluorescent dye used for studying axons 2 position on pyrimidine ring may be S or O; RN given refers to Na salt; structure

Names & identifiers

Preferred name
Merocyanine I
IUPAC
sodium 3-[(2Z)-2-[(E)-4-(1,3-dibutyl-2,4,6-trioxo-1,3-diazinan-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonate

Names & synonyms

Merocyanine dyeMerocyanine I7V7WD5EDT7DTXSID701027218RefChem:156623DTXCID301511493MC 540merocyanine58823-12-4Sodium 2-(4-(1,3-dibutyltetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-2-butenylidene)-3(2H)-benzoxazolepropanesulfonateUNII-7V7WD5EDT7SCHEMBL19876733
Show more names
DZVCFNFOPIZQKX-LTHRDKTGSA-M3(2H)-Benzoxazolepropanesulfonic acid, 2-(4-(1,3-dibutyltetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-2-butenylidene)-, sodium saltsodium;3-[(2Z)-2-[(E)-4-(1,3-dibutyl-2,4,6-trioxo-1,3-diazinan-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonateQ59772953(2H)-Benzoxazolepropanesulfonic acid, 2-[4-(1,3-dibutyltetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-2-buten-1-ylidene]-, sodium salt (1:1)

Database identifiers

CAS
58823-12-4
PubChem CID
23678802
UNII
7V7WD5EDT7

Properties

Computed structural properties

Topological polar surface area
136 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
8
Rotatable bonds
12
Heavy atoms
38
Formal charge
0
Complexity
1,020

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 4 items

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags.

Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.

Related reactions

3 records
New reaction record
HRID 1292456 reaction equation
HRID 1292456As reactant
HRID 1679502 reaction equation
HRID 1679502As reactant
HRID 2398526 reaction equation
HRID 2398526As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes